|
US2642514A
(en)
|
1946-08-10 |
1953-06-16 |
American Cyanamid Co |
Ion exchange process with magnetic ion exchange resins
|
|
GB1239978A
(en)
|
1968-07-15 |
1971-07-21 |
Permutt Company Ltd |
Ion-exchange processes
|
|
US4709016A
(en)
|
1982-02-01 |
1987-11-24 |
Northeastern University |
Molecular analytical release tags and their use in chemical analysis
|
|
US5650270A
(en)
|
1982-02-01 |
1997-07-22 |
Northeastern University |
Molecular analytical release tags and their use in chemical analysis
|
|
US4650750A
(en)
|
1982-02-01 |
1987-03-17 |
Giese Roger W |
Method of chemical analysis employing molecular release tag compounds
|
|
US5516931A
(en)
|
1982-02-01 |
1996-05-14 |
Northeastern University |
Release tag compounds producing ketone signal groups
|
|
US5595756A
(en)
|
1993-12-22 |
1997-01-21 |
Inex Pharmaceuticals Corporation |
Liposomal compositions for enhanced retention of bioactive agents
|
|
US20020164788A1
(en)
|
1994-12-02 |
2002-11-07 |
The Wellcome Foundation Limited |
Humanized antibodies to CD38
|
|
WO1997008320A1
(en)
|
1995-08-18 |
1997-03-06 |
Morphosys Gesellschaft Für Proteinoptimierung Mbh |
Protein/(poly)peptide libraries
|
|
EP0941120A4
(en)
|
1996-11-05 |
2004-08-18 |
Bristol Myers Squibb Co |
BRANCHED PEPTIDLINKERS
|
|
US6326144B1
(en)
|
1998-09-18 |
2001-12-04 |
Massachusetts Institute Of Technology |
Biological applications of quantum dots
|
|
JP4630459B2
(ja)
|
1998-09-24 |
2011-02-09 |
インディアナ・ユニバーシティ・リサーチ・アンド・テクノロジー・コーポレーション |
水溶性発光量子ドットおよびその生体分子コンジュゲート
|
|
US6927203B1
(en)
|
1999-08-17 |
2005-08-09 |
Purdue Research Foundation |
Treatment of metastatic disease
|
|
AU2003217606C1
(en)
|
2002-02-21 |
2008-07-17 |
Institute Of Virology |
Soluble Form of Carbonic Anhydrase IX (s-CA IX), Assays to Detect s-CA IX, CA IXs Coexpression with HER-2/neu/c-erbB-2 and CA IX-Specific Monoclonal Antibodies to Non-Immunodominant Epitopes
|
|
AU2003286411A1
(en)
|
2002-12-12 |
2004-06-30 |
Tel Aviv University Future Technology Development L.P. |
Glycogen synthase kinase-3 inhibitors
|
|
EP1452868A2
(en)
|
2003-02-27 |
2004-09-01 |
Pepscan Systems B.V. |
Method for selecting a candidate drug compound
|
|
NZ548990A
(en)
|
2004-02-06 |
2009-06-26 |
Morphosys Ag |
Anti-CD38 human antibodies and uses therefor
|
|
CA2505655C
(en)
|
2004-04-28 |
2013-07-09 |
Warren Chan |
Stable, water-soluble quantum dot, method of preparation and conjugates thereof
|
|
WO2006078161A1
(en)
|
2005-01-24 |
2006-07-27 |
Pepscan Systems B.V. |
Binding compounds, immunogenic compounds and peptidomimetics
|
|
PL1866328T3
(pl)
|
2005-03-22 |
2011-05-31 |
Rohto Pharma |
Peptydy zwiększające wytwarzanie kolagenu lub kwasu hialuronowego
|
|
AU2006287416A1
(en)
|
2005-09-07 |
2007-03-15 |
Medimmune, Llc |
Toxin conjugated Eph receptor antibodies
|
|
WO2007093836A1
(en)
|
2006-02-13 |
2007-08-23 |
Cellectis |
Meganuclease variants cleaving a dna target sequence from a xp gene and uses thereof
|
|
WO2008033561A2
(en)
|
2006-09-15 |
2008-03-20 |
Siemens Medical Solutions Usa, Inc. |
Click chemistry-derived cyclopeptide derivatives as imaging agents for integrins
|
|
CN101232326B
(zh)
|
2007-01-22 |
2012-01-11 |
中兴通讯股份有限公司 |
用于无源光网络系统的动态带宽分配装置及其实现方法
|
|
WO2008134761A2
(en)
|
2007-04-30 |
2008-11-06 |
Intezyne Technologies, Inc. |
Modification of biological targeting groups for the treatment of cancer
|
|
CN101918844A
(zh)
|
2007-06-18 |
2010-12-15 |
米迪缪尼有限公司 |
表达epha2和erbb2的细胞的协同治疗
|
|
WO2009097397A2
(en)
|
2008-01-30 |
2009-08-06 |
Dyax Corp. |
Metalloproteinase binding proteins
|
|
CN101497878B
(zh)
|
2008-01-30 |
2012-11-07 |
房学迅 |
特异性高效亲和膜ⅰ型基质金属蛋白酶(mt1-mmp)的多肽、蛋白及其应用
|
|
DK2257624T5
(da)
*
|
2008-02-05 |
2012-09-10 |
Medical Res Council |
Fremgangsmåder og sammensætninger
|
|
DK2257309T3
(da)
|
2008-02-27 |
2020-01-20 |
Yeda Res And Development Company Ltd |
Rgd-(bakterie)chlorophyl-konjugater til anvendelse ved diagnose af tumorer, der omfatter nekrotiske domæner
|
|
US8293714B2
(en)
|
2008-05-05 |
2012-10-23 |
Covx Technology Ireland, Ltd. |
Anti-angiogenic compounds
|
|
FR2932189A1
(fr)
|
2008-06-10 |
2009-12-11 |
Commissariat Energie Atomique |
Biopuces pour la detection de l'activite enzymatique d'une enzyme protease
|
|
GB0913775D0
(en)
|
2009-08-06 |
2009-09-16 |
Medical Res Council |
Multispecific peptides
|
|
US20120183847A1
(en)
|
2009-05-19 |
2012-07-19 |
Aic Blab |
Composite current collector and methods therefor
|
|
GB0914110D0
(en)
|
2009-08-12 |
2009-09-16 |
Medical Res Council |
Peptide libraries
|
|
AU2010321738B2
(en)
|
2009-11-23 |
2016-07-14 |
Palatin Technologies, Inc. |
Melanocortin-1 receptor-specific cyclic peptides
|
|
US9073974B2
(en)
|
2009-12-21 |
2015-07-07 |
The Regents Of The University Of California |
RGD-containing cyclic peptides
|
|
EP2343081A1
(en)
|
2009-12-31 |
2011-07-13 |
Rijksuniversiteit Groningen |
Interferon analogs
|
|
WO2012057624A1
(en)
|
2010-10-25 |
2012-05-03 |
Pepscan Systems B.V. |
Novel bicyclic peptide mimetics
|
|
US20130072598A1
(en)
|
2011-03-18 |
2013-03-21 |
Board Of Regents Of The University Of Nebraska |
Thermoplastics from Distillers Dried Grains and Feathers
|
|
GB201117428D0
(en)
|
2011-10-07 |
2011-11-23 |
Bicycle Therapeutics Ltd |
Structured polypeptides with sarcosine linkers
|
|
US10800813B2
(en)
|
2011-10-07 |
2020-10-13 |
Bicyclerd Limited |
Modulation of structured polypeptide specificity
|
|
WO2014044873A1
(en)
|
2012-09-24 |
2014-03-27 |
Allozyne, Inc |
Amino acid derivatives
|
|
WO2014063012A1
(en)
|
2012-10-19 |
2014-04-24 |
The Board Of Trustees Of The Leland Stanford Junior University |
Conjugated knottin mini-proteins containing non-natural amino acids
|
|
EP2970487B1
(en)
|
2013-03-12 |
2020-03-11 |
Molecular Templates, Inc. |
Cytotoxic proteins comprising cell-targeting binding regions and shiga toxin a subunit regions for selective killing of specific cell types
|
|
US20140274759A1
(en)
*
|
2013-03-15 |
2014-09-18 |
Bicycle Therapeutics Limited |
Modification of polypeptides
|
|
EP2976362B1
(en)
|
2013-03-19 |
2019-10-23 |
Beijing Shenogen Pharma Group Ltd. |
Antibodies and methods for treating estrogen receptor-associated diseases
|
|
GB201306623D0
(en)
|
2013-04-11 |
2013-05-29 |
Bicycle Therapeutics Ltd |
Modulation of structured polypeptide specificity
|
|
ES2705068T3
(es)
|
2013-05-23 |
2019-03-21 |
Ohio State Innovation Foundation |
Síntesis química y cribado de bibliotecas de péptidos bicíclicos
|
|
RU2715232C2
(ru)
|
2013-09-25 |
2020-02-26 |
Сайтомкс Терапьютикс, Инк. |
Субстраты матриксной металлопротеиназы и другие расщипляемые фрагменты и способы их использования
|
|
EP3062823B1
(en)
|
2013-10-28 |
2018-12-12 |
BicycleRD Limited |
Novel polypeptides
|
|
SI3102576T1
(sl)
|
2014-02-03 |
2019-08-30 |
Vitae Pharmaceuticals, Llc |
Inhibitorji dihidropirolopiridina ROR-gama
|
|
JP6875129B2
(ja)
|
2014-05-08 |
2021-05-19 |
ノボダイアックス， インコーポレイテッド |
直接的な免疫組織化学アッセイ
|
|
RS59119B1
(sr)
|
2014-05-21 |
2019-09-30 |
Entrada Therapeutics Inc |
Peptidi koji prodiru u ćelije i postupci za njihovo pravljenje i upotrebu
|
|
GB201416960D0
(en)
|
2014-09-25 |
2014-11-12 |
Antikor Biopharma Ltd |
Biological materials and uses thereof
|
|
JP6917887B2
(ja)
|
2014-09-30 |
2021-08-11 |
ポリフォー・アクチェンゲゼルシャフトＰｏｌｙｐｈｏｒ Ａｇ |
ベータ−ヘアピンペプチド模倣体
|
|
CA2963556C
(en)
|
2014-10-24 |
2023-03-14 |
Research Corporation Technologies, Inc. |
Small antibody-like polypeptides that bind to epha2 receptor
|
|
RS61853B1
(sr)
|
2014-10-29 |
2021-06-30 |
Bicyclerd Ltd |
Biciklični peptidni ligandi specifični za mt1-mmp
|
|
JP2017537893A
(ja)
|
2014-10-31 |
2017-12-21 |
アッヴィ・バイオセラピューティクス・インコーポレイテッド |
抗ｃｓ１抗体および抗体薬結合体
|
|
ES2986970T3
(es)
|
2014-12-04 |
2024-11-13 |
Celgene Corp |
Conjugados de biomoléculas
|
|
IL237525A
(en)
|
2015-03-03 |
2017-05-29 |
Shalom Eli |
Method for labeling a prostate-specific membrane antigen with a radioactive isotope
|
|
US10864101B2
(en)
|
2015-04-22 |
2020-12-15 |
Mitsui Chemicals, Inc. |
Garment provided with joint supporter section, and knee supporter
|
|
WO2016171242A1
(ja)
|
2015-04-24 |
2016-10-27 |
第一三共株式会社 |
Ｅｐｈａ２の検出
|
|
JP2018521960A
(ja)
|
2015-04-28 |
2018-08-09 |
エコール・ポリテクニーク・フェデラル・ドゥ・ローザンヌ（ウペエフエル）Ｅｃｏｌｅ Ｐｏｌｙｔｅｃｈｎｉｑｕｅ Ｆｅｄｅｒａｌｅ ｄｅ Ｌａｕｓａｎｎｅ （ＥＰＦＬ） |
酵素で活性化された第ＸＩＩ因子（ＦＸＩＩａ）の新規阻害剤
|
|
WO2016179534A2
(en)
|
2015-05-06 |
2016-11-10 |
Janssen Biotech, Inc. |
Prostate specific membrane antigen binding fibronectin type iii domains
|
|
EP3115066A1
(en)
|
2015-07-07 |
2017-01-11 |
Technische Universität München |
Novel psma-specific binding proteins
|
|
US9963495B2
(en)
|
2015-10-27 |
2018-05-08 |
The Board Of Trustees Of The Leland Stanford Junior University |
Polypeptides targeting vascular endothelial growth factor receptor and prostate specific membrane antigen
|
|
EP3181146A1
(en)
|
2015-12-16 |
2017-06-21 |
Ruprecht-Karls-Universität Heidelberg |
Cyclic ntcp-targeting peptides and their uses as entry inhibitors
|
|
GB201600903D0
(en)
*
|
2016-01-18 |
2016-03-02 |
Bicycle Therapeutics Ltd |
Peptide derivaties
|
|
GB201600911D0
(en)
|
2016-01-18 |
2016-03-02 |
Bicycle Therapeutics Ltd |
Stabilized peptide derivatives
|
|
US10765625B2
(en)
|
2016-03-15 |
2020-09-08 |
The Board Of Trustees Of The Leland Stanford Junior University |
Knottin-drug conjugates and methods of using the same
|
|
KR20180121905A
(ko)
|
2016-03-16 |
2018-11-09 |
메리맥 파마슈티컬즈, 인크. |
에프린 수용체 a2(epha2)의 나노리포솜 표적화 및 관련된 진단
|
|
KR102775461B1
(ko)
|
2016-04-01 |
2025-02-28 |
어비디티 바이오사이언시스 인크. |
핵산-폴리펩타이드 조성물 및 이의 용도
|
|
US10836796B2
(en)
|
2016-04-20 |
2020-11-17 |
Hangzhou Dac Biotech Co., Ltd. |
Derivatives of amanita toxins and their conjugation to a cell binding molecule
|
|
RU2018139339A
(ru)
|
2016-04-22 |
2020-05-22 |
Эллигейтор Биосайенс Аб |
Новые биспецифические полипептиды против cd137
|
|
GB201607827D0
(en)
|
2016-05-04 |
2016-06-15 |
Bicycle Therapeutics Ltd |
Bicyclic peptide-toxin conjugates specific for MT1-MMP
|
|
SG11201810591VA
(en)
|
2016-05-27 |
2018-12-28 |
Abbvie Biotherapeutics Inc |
Bispecific binding proteins binding an immunomodulatory protein and a tumor antigen
|
|
WO2018096365A1
(en)
|
2016-11-27 |
2018-05-31 |
Bicyclerd Limited |
Methods for treating cancer
|
|
US11730819B2
(en)
|
2016-12-23 |
2023-08-22 |
Bicycletx Limited |
Peptide derivatives having novel linkage structures
|
|
CN110506049B
(zh)
|
2016-12-23 |
2024-08-16 |
拜斯科技术开发有限公司 |
用于结合mt1-mmp的肽配体
|
|
WO2018127699A1
(en)
|
2017-01-06 |
2018-07-12 |
Bicyclerd Limited |
Compounds for treating cancer
|
|
SG11201907753TA
(en)
|
2017-02-24 |
2019-09-27 |
Macrogenics Inc |
Bispecific binding molecules that are capable of binding cd137 and tumor antigens, and uses thereof
|
|
GB201706477D0
(en)
|
2017-04-24 |
2017-06-07 |
Bicycle Therapeutics Ltd |
Modification of polypeptides
|
|
EP3615550A1
(en)
|
2017-04-27 |
2020-03-04 |
BicycleTx Limited |
Bicyclic peptide ligands and uses thereof
|
|
WO2018222987A1
(en)
|
2017-06-01 |
2018-12-06 |
Tarveda Therapeutics, Inc. |
Targeted constructs
|
|
EP3645549A1
(en)
|
2017-06-26 |
2020-05-06 |
BicycleRD Limited |
Bicyclic peptide ligands with detectable moieties and uses thereof
|
|
JP7670481B2
(ja)
|
2017-08-04 |
2025-04-30 |
バイスクルテクス・リミテッド |
Ｃｄ１３７に対して特異的な二環式ペプチドリガンド
|
|
US20200291096A1
(en)
|
2017-08-14 |
2020-09-17 |
Bicyclerd Limited |
Bicyclic peptide ligand sting conjugates and uses thereof
|
|
US20200283482A1
(en)
|
2017-08-14 |
2020-09-10 |
Bicyclerd Limited |
Bicyclic peptide ligand prr-a conjugates and uses thereof
|
|
WO2019084060A1
(en)
|
2017-10-24 |
2019-05-02 |
Silverback Therapeutics, Inc. |
CONJUGATES AND METHODS OF USE FOR THE SELECTIVE DELIVERY OF IMMUNOMODULATORY AGENTS
|
|
JP7426931B2
(ja)
|
2017-11-07 |
2024-02-02 |
レゲネロン ファーマシューティカルス，インコーポレーテッド |
抗体薬物コンジュゲートのための親水性リンカー
|
|
TWI825046B
(zh)
|
2017-12-19 |
2023-12-11 |
英商拜西可泰克斯有限公司 |
Epha2特用之雙環胜肽配位基
|
|
GB201721265D0
(en)
|
2017-12-19 |
2018-01-31 |
Bicyclerd Ltd |
Bicyclic peptide ligands specific for EphA2
|
|
WO2019136442A1
(en)
|
2018-01-08 |
2019-07-11 |
Kleo Pharmaceuticals, Inc. |
Cd16a binding agents and uses thereof
|
|
KR20200128518A
(ko)
|
2018-02-23 |
2020-11-13 |
바이사이클티엑스 리미티드 |
다량체성 비사이클릭 펩타이드 리간드
|
|
KR20200139236A
(ko)
|
2018-04-04 |
2020-12-11 |
바이사이클티엑스 리미티드 |
헤테로탠덤 비사이클릭 펩티드 복합체
|
|
EP3797120A1
(en)
|
2018-05-21 |
2021-03-31 |
Compass Therapeutics LLC |
Compositions and methods for enhancing the killing of target cells by nk cells
|
|
GB201810327D0
(en)
|
2018-06-22 |
2018-08-08 |
Bicycletx Ltd |
Peptide ligands for binding to IL-17
|
|
US11180531B2
(en)
|
2018-06-22 |
2021-11-23 |
Bicycletx Limited |
Bicyclic peptide ligands specific for Nectin-4
|
|
GB201810316D0
(en)
|
2018-06-22 |
2018-08-08 |
Bicyclerd Ltd |
Peptide ligands for binding to EphA2
|
|
GB201810329D0
(en)
|
2018-06-22 |
2018-08-08 |
Bicycletx Ltd |
Peptide ligands for binding to integrin avB3
|
|
GB201810325D0
(en)
|
2018-06-22 |
2018-08-08 |
Bicycletx Ltd |
Peptide ligands for binding to PSMA
|
|
GB201810320D0
(en)
|
2018-06-22 |
2018-08-08 |
Bicycletx Ltd |
Peptide ligands for binding to CD38
|
|
CN112955459A
(zh)
|
2018-10-23 |
2021-06-11 |
拜斯科技术开发有限公司 |
双环肽配体和其用途
|
|
SG11202104356VA
(en)
|
2018-10-30 |
2021-05-28 |
Bicyclerd Ltd |
Bt1718 for use in treating cancer
|
|
GB201820325D0
(en)
|
2018-12-13 |
2019-01-30 |
Bicyclerd Ltd |
Bicyclic peptide ligands specific for psma
|
|
GB201820295D0
(en)
|
2018-12-13 |
2019-01-30 |
Bicyclerd Ltd |
Bicyclic peptide ligands specific for MT1-MMP
|
|
US20220024982A1
(en)
|
2018-12-13 |
2022-01-27 |
Bicycletx Limited |
Bicyclic peptide ligands specific for mt1-mmp
|
|
GB201820288D0
(en)
|
2018-12-13 |
2019-01-30 |
Bicycle Tx Ltd |
Bicycle peptide ligaands specific for MT1-MMP
|
|
CA3120800A1
(en)
|
2018-12-17 |
2020-06-25 |
Revitope Limited |
Twin immune cell engager
|
|
CN113474045A
(zh)
|
2018-12-21 |
2021-10-01 |
拜斯科技术开发有限公司 |
Pd-l1特异性的双环肽配体
|
|
WO2020128527A1
(en)
|
2018-12-21 |
2020-06-25 |
Bicyclerd Limited |
Bicyclic peptide ligands specific for pd-l1
|
|
US10882987B2
(en)
|
2019-01-09 |
2021-01-05 |
Nova Chemicals (International) S.A. |
Ethylene interpolymer products having intermediate branching
|
|
GB201900526D0
(en)
|
2019-01-15 |
2019-03-06 |
Bicyclerd Ltd |
Bicyclic peptide ligands specific for caix
|
|
GB201900525D0
(en)
|
2019-01-15 |
2019-03-06 |
Bicycletx Ltd |
Bicyclic peptide ligands specific for caix
|
|
GB201900527D0
(en)
|
2019-01-15 |
2019-03-06 |
Bicycletx Ltd |
Bicyclic peptide ligands specific for integrin avb3
|
|
GB201900528D0
(en)
|
2019-01-15 |
2019-03-06 |
Bicyclerd Ltd |
Bicyclic peptide ligands specific for integrin AVB3
|
|
GB201900530D0
(en)
|
2019-01-15 |
2019-03-06 |
Bicyclerd Ltd |
Bicyclic peptide ligands specific for CD38
|
|
GB201900529D0
(en)
|
2019-01-15 |
2019-03-06 |
Bicycletx Ltd |
Bicyclic peptide ligands specific for CD38
|
|
WO2020165600A1
(en)
|
2019-02-14 |
2020-08-20 |
Bicycletx Limited |
Bicyclic peptide ligand sting conjugates and uses thereof
|
|
US20220135614A1
(en)
|
2019-03-04 |
2022-05-05 |
Bicyclerd Limited |
Synthesis of bicycle toxin conjugates, and intermediates thereof
|
|
AU2020253990A1
(en)
|
2019-04-02 |
2021-10-28 |
Bicycletx Limited |
Bicycle toxin conjugates and uses thereof
|
|
WO2020225577A1
(en)
|
2019-05-09 |
2020-11-12 |
Bicycletx Limited |
Bicyclic peptide ligands specific for ox40
|
|
TWI869398B
(zh)
|
2019-05-10 |
2025-01-11 |
英商拜西克爾德有限公司 |
治療癌症之方法
|
|
TWI862640B
(zh)
|
2019-07-30 |
2024-11-21 |
英商拜西可泰克斯有限公司 |
異質雙環肽複合物
|
|
WO2021028686A1
(en)
|
2019-08-13 |
2021-02-18 |
Bicycletx Limited |
Modified multimeric bicyclic peptide ligands
|
|
GB201912320D0
(en)
|
2019-08-28 |
2019-10-09 |
Bicycletx Ltd |
PBP Binding Bicyclic Peptide Ligands
|
|
PT4464721T
(pt)
|
2019-10-03 |
2025-06-24 |
Bicycletx Ltd |
Complexos peptídicos bicíclicos heterotandem
|
|
GB201914872D0
(en)
|
2019-10-15 |
2019-11-27 |
Bicycletx Ltd |
Bicyclic peptide ligand drug conjugates
|
|
US20220387611A1
(en)
|
2019-10-16 |
2022-12-08 |
Bicyclerd Limited |
Methods for treating cancer
|
|
CA3158741A1
(en)
|
2019-11-27 |
2021-06-03 |
Gavin Bennett |
Bicyclic peptide ligands specific for epha2 and uses thereof
|
|
IT202000001231A1
(it)
|
2020-01-22 |
2021-07-22 |
Celery S R L |
Nuovi ceppi di batteri lattici, composizione alimentare che li comprende, preparazione di tale composizione
|
|
GB202002706D0
(en)
|
2020-02-26 |
2020-04-08 |
Bicycletx Ltd |
Pbp3 binding bicyclic peptide ligands
|
|
GB202002705D0
(en)
|
2020-02-26 |
2020-04-08 |
Bicycletx Ltd |
Anti-infective bicyclic peptide conjugates
|
|
KR20230037502A
(ko)
|
2020-05-20 |
2023-03-16 |
바이사이클티엑스 리미티드 |
넥틴-4에 특이적인 바이사이클릭 펩티드 리간드 및 이의 용도
|
|
IL298868A
(en)
|
2020-06-12 |
2023-02-01 |
Bicycletx Ltd |
Treatment of diseases characterized by overexpression of hepatocyte receptor A2 that produces erythropoietin (EPHA2)
|
|
KR20230074119A
(ko)
|
2020-08-03 |
2023-05-26 |
바이사이클티엑스 리미티드 |
펩타이드 기반 링커
|
|
EP4196792A1
(en)
|
2020-08-17 |
2023-06-21 |
BicycleTX Limited |
Bicycle conjugates specific for nectin-4 and uses thereof
|
|
ES2992468T3
(es)
|
2021-01-08 |
2024-12-12 |
Bicycletx Ltd |
Ligandos peptídicos bicíclicos específicos para linfocitos NK
|
|
CN117157305A
(zh)
|
2021-01-08 |
2023-12-01 |
拜斯科技术开发有限公司 |
抗感染的双环肽配体
|
|
CA3206529A1
(en)
|
2021-01-08 |
2022-07-14 |
Bicycletx Limited |
Heterotandem bicyclic peptide complexes
|
|
US20250186539A2
(en)
|
2021-01-11 |
2025-06-12 |
Bicycletx Limited |
Methods for treating cancer
|
|
AU2022340959A1
(en)
|
2021-09-03 |
2024-03-07 |
Bicycletx Limited |
Synthesis of bicycle toxin conjugates, and intermediates thereof
|
|
KR20240100420A
(ko)
|
2021-11-16 |
2024-07-01 |
바이사이클티엑스 리미티드 |
암을 치료하기 위한 방법
|